SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001114220-18-000036
Filing Date
2018-03-22
Accepted
2018-03-22 17:31:26
Documents
2
Period of Report
2018-03-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_152175427253984.html 4  
1 FORM 4 wf-form4_152175427253984.xml 4 6078
2 CHRISTINE CARBERRY POWER OF ATTORNEY - FEB 2018 ex-24.htm EX-24 2967
  Complete submission text file 0001114220-18-000036.txt   10421
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MARINA PARK DRIVE, 12TH FLOOR C/O KERYX BIOPHARMACEUTICALS, INC. BOSTON MA 02210
Business Address
Carberry Christine A. (Reporting) CIK: 0001694459 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 18707778